Literature DB >> 8524812

Phosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium.

Z Wu1, C T Walsh.   

Abstract

VanX is a D-Ala-D-Ala dipeptidase that is essential for vancomycin resistance in Enterococcus faecium. Contrary to most proteases and peptidases, it prefers to hydrolyze the amino substrate but not the related kinetically and thermodynamically more favorable ester substrate D-Ala-D-lactate. The enzymatic activity of VanX was previously found to be inhibited by the phosphinate analogs of the proposed tetrahedral intermediate for hydrolysis of D-Ala-D-Ala. Here we report that such phosphinates are slow-binding inhibitors. D-3-[(1-Aminoethyl)phosphinyl]-D-2-methylpropionic acid I showed a time-dependent onset of inhibition of VanX and a time-dependent return to uninhibited steady-state rates upon dilution of the enzyme/inhibitor mixture. The initial inhibition constant Ki after immediate addition of VanX to phosphinate I to form the E-I complex is 1.5 microM but is then lowered by a relatively slow isomerization step to a second complex, E-I*, with a final K*i of 0.47 microM. This slow-binding inhibition reflects a Km/K*i ratio of 2900:1. The rate constant for the slow dissociation of complex E-I* is 0.24 min-1. A phosphinate analog with an ethyl group replacing what would be the side chain of the second D-alanyl residue in the normal tetrahedral adduct gives a K*i value of 90 nM. Partial proteolysis of VanX reveals two protease-sensitive loop regions that are protected by the intermediate analog phosphinate, indicating that they may be part of the VanX active site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524812      PMCID: PMC40450          DOI: 10.1073/pnas.92.25.11603

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  1-Aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behavior.

Authors:  M D Erion; C T Walsh
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

2.  Prediction of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

3.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

Review 4.  The structure and mode of action of glycopeptide antibiotics of the vancomycin group.

Authors:  J C Barna; D H Williams
Journal:  Annu Rev Microbiol       Date:  1984       Impact factor: 15.500

5.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  ATP-dependent inactivation and slow binding inhibition of Salmonella typhimurium D-alanine:D-alanine ligase (ADP) by (aminoalkyl)phosphinate and aminophosphonate analogues of D-alanine.

Authors:  K Duncan; C T Walsh
Journal:  Biochemistry       Date:  1988-05-17       Impact factor: 3.162

7.  Overexpression, purification, and characterization of VanX, a D-, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147.

Authors:  Z Wu; G D Wright; C T Walsh
Journal:  Biochemistry       Date:  1995-02-28       Impact factor: 3.162

8.  Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium.

Authors:  T R Holman; Z Wu; B L Wanner; C T Walsh
Journal:  Biochemistry       Date:  1994-04-19       Impact factor: 3.162

9.  Active site mapping of Escherichia coli D-Ala-D-Ala ligase by structure-based mutagenesis.

Authors:  Y Shi; C T Walsh
Journal:  Biochemistry       Date:  1995-03-07       Impact factor: 3.162

10.  Vancomycin resistance: structure of D-alanine:D-alanine ligase at 2.3 A resolution.

Authors:  C Fan; P C Moews; C T Walsh; J R Knox
Journal:  Science       Date:  1994-10-21       Impact factor: 47.728

View more
  7 in total

1.  Probing the reaction mechanism of the D-ala-D-ala dipeptidase, VanX, by using stopped-flow kinetic and rapid-freeze quench EPR studies on the Co(II)-substituted enzyme.

Authors:  Megan L Matthews; Gopalraj Periyannan; Christine Hajdin; Tara K Sidgel; Brian Bennett; Michael W Crowder
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

3.  A thioredoxin fusion protein of VanH, a D-lactate dehydrogenase from Enterococcus faecium: cloning, expression, purification, kinetic analysis, and crystallization.

Authors:  V S Stoll; A V Manohar; W Gillon; E L MacFarlane; R C Hynes; E F Pai
Journal:  Protein Sci       Date:  1998-05       Impact factor: 6.725

Review 4.  VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function?

Authors:  I A Lessard; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 5.  Glycopeptide antibiotics: from conventional molecules to new derivatives.

Authors:  Françoise Van Bambeke; Yves Van Laethem; Patrice Courvalin; Paul M Tulkens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases.

Authors:  Ke-Wu Yang; Lei Feng; Shao-Kang Yang; Mahesh Aitha; Alecander E LaCuran; Peter Oelschlaeger; Michael W Crowder
Journal:  Bioorg Med Chem Lett       Date:  2013-09-08       Impact factor: 2.823

Review 7.  Synthesis and modifications of phosphinic dipeptide analogues.

Authors:  Artur Mucha
Journal:  Molecules       Date:  2012-11-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.